Dudediligence.

Veracyte, Inc

VCYTNASDAQ · Services-Medical Laboratories
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$115.9MSep ’24$118.6MDec ’24$114.5MMar ’25$130.2MJun ’25$131.9MSep ’25$140.6MDec ’25$139.1MMar ’26$150.3MJun ’26
Net income, by quarter
$15.2MSep ’24$5.1MDec ’24$7.0MMar ’25−$980,000Jun ’25$19.1MSep ’25$41.2MDec ’25$28.7MMar ’26$25.5MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$219.5M$296.5M$361.1M$445.8M$517.1M
Gross profitnone on file$175.7M$229.7M$298.1M$362.5M
Operating income−$81.9M−$41.1M−$85.8M$16.1M$57.8M
Net income−$75.6M−$36.6M−$74.4M$24.1M$66.4M
Operating cash flow−$31.6M$7.5M$44.2M$75.1M$136.3M
Free cash flow−$37.0M−$1.0M$34.3M$63.8M$126.6M
Cash$173.2M$154.2M$216.5M$239.1M$362.6M
Debt$1.1M$0.00none on filenone on filenone on file
Shares outstanding71.1M72.0M73.3M77.8M79.4M